Filing Details

Accession Number:
0001209191-16-128018
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-15 17:19:11
Reporting Period:
2016-06-15
Filing Date:
2016-06-15
Accepted Time:
2016-06-15 17:19:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Plc HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1619077 Virinder Nohria C/O Horizon Pharma Plc
Connaught House, 1St Fl, 1 Burlington Rd
Dublin L2 4
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2016-06-15 25,000 $17.69 189,836 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Ordinary Shares 5,258 Indirect By Trust
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.65 to $17.77 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.